Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Karmanos Cancer Institute Receives 2025 Women’s Choice Awards® for Cancer Care, Mammogram Imaging, Minimally Invasive Surgery and Patient Experience

The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2025 Best Hospitals for Cancer Care, Mammogram Imaging, Minimally Invasi...

Read More

A Melody of Courage: Sierra’s Cancer Journey After Being Diagnosed with Hodgkin Lymphoma

From a young age, music has been a big part of Sierra Watson’s life. In seventh grade, she started playing the bassoon. It became a passion of her...

Read More

IN THE NEWS – NSCLC: Racial and Socioeconomic Disparities in Survival Rates

MedPage Today Dipesh Uprety, M.D., FACP , medical oncologist, member of the  Phase I Clinical Trials  and  Thoracic Oncology  ...

Read More
News

WDET | Cancer Warning Label on Alcohol

Listen Now

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now